---
layout: post
title: "Her2 Challenge Contest: A Detailed Assessment of Automated Her2 Scoring Algorithms in Whole Slide Images of Breast Cancer Tissues"
date: 2017-07-24 21:39:53
categories: arXiv_CV
tags: arXiv_CV
author: Talha Qaiser, Abhik Mukherjee, Chaitanya Reddy Pb, Sai Dileep Munugoti, Vamsi Tallam, Tomi Pitkäaho, Taina Lehtimäki, Thomas Naughton, Matt Berseth, Aníbal Pedraza, Ramakrishnan Mukundan, Matthew Smith, Abhir Bhalerao, Erik Rodner, Marcel Simon, Joachim Denzler, Chao-Hui Huang, Gloria Bueno, David Snead, Ian Ellis, Mohammad Ilyas, Nasir Rajpoot
mathjax: true
---

* content
{:toc}

##### Abstract
Evaluating expression of the Human epidermal growth factor receptor 2 (Her2) by visual examination of immunohistochemistry (IHC) on invasive breast cancer (BCa) is a key part of the diagnostic assessment of BCa due to its recognised importance as a predictive and prognostic marker in clinical practice. However, visual scoring of Her2 is subjective and consequently prone to inter-observer variability. Given the prognostic and therapeutic implications of Her2 scoring, a more objective method is required. In this paper, we report on a recent automated Her2 scoring contest, held in conjunction with the annual PathSoc meeting held in Nottingham in June 2016, aimed at systematically comparing and advancing the state-of-the-art Artificial Intelligence (AI) based automated methods for Her2 scoring. The contest dataset comprised of digitised whole slide images (WSI) of sections from 86 cases of invasive breast carcinoma stained with both Haematoxylin & Eosin (H&E) and IHC for Her2. The contesting algorithms automatically predicted scores of the IHC slides for an unseen subset of the dataset and the predicted scores were compared with the 'ground truth' (a consensus score from at least two experts). We also report on a simple Man vs Machine contest for the scoring of Her2 and show that the automated methods could beat the pathology experts on this contest dataset. This paper presents a benchmark for comparing the performance of automated algorithms for scoring of Her2. It also demonstrates the enormous potential of automated algorithms in assisting the pathologist with objective IHC scoring.

##### Abstract (translated by Google)
通过对浸润性乳腺癌（BCa）的免疫组织化学（IHC）的视觉检查来评估人表皮生长因子受体2（Her2）的表达是BCa的诊断评估的关键部分，因为其被公认为重要的预测性和预后指标临床实践。然而，Her2的视觉评分是主观的，因此倾向于观察者间的差异。鉴于Her2评分的预后和治疗意义，需要更客观的方法。在本文中，我们报告了最近的一次自动Her2得分比赛，与2016年6月在诺丁汉举行的年度PathSoc会议一起举行，旨在系统地比较和推进基于最先进的基于人工智能（AI）的自动化Her2得分方法。比赛数据集包括86例浸润性乳腺癌和苏木素 - 伊红（H＆E）和IHC（用于Her2）的切片的数字化整幅载玻片图像（WSI）。竞赛算法自动预测了一个看不见的数据集子集的IHC幻灯片分数，并将预测分数与“基本事实”（至少两位专家的共识分数）进行比较。我们还报道了一个简单的人与机器比赛Her2的得分，并显示自动方法可以击败这个比赛数据集的病理专家。本文提供了一个比较Her2评分自动化算法性能的基准。它还展示了自动算法在帮助病理学家获得IHC评分方面的巨大潜力。

##### URL
[https://arxiv.org/abs/1705.08369](https://arxiv.org/abs/1705.08369)

##### PDF
[https://arxiv.org/pdf/1705.08369](https://arxiv.org/pdf/1705.08369)

